Mary L. Hall

574 total citations
31 papers, 433 citations indexed

About

Mary L. Hall is a scholar working on Immunology, Neurology and Molecular Biology. According to data from OpenAlex, Mary L. Hall has authored 31 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Neurology and 7 papers in Molecular Biology. Recurrent topics in Mary L. Hall's work include Neuroinflammation and Neurodegeneration Mechanisms (9 papers), Salmonella and Campylobacter epidemiology (7 papers) and Immune Response and Inflammation (6 papers). Mary L. Hall is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (9 papers), Salmonella and Campylobacter epidemiology (7 papers) and Immune Response and Inflammation (6 papers). Mary L. Hall collaborates with scholars based in United States, Nepal and United Kingdom. Mary L. Hall's co-authors include B. Rowe, Alejandro M. S. Mayer, E. J. Threlfall, Patrick M. Schlievert, Philip G. Williams, Diane Roberts, Michael J. Fay, Michelle Swanson‐Mungerson, Keith B. Glaser and John P. Berry and has published in prestigious journals such as The Journal of Immunology, Clinical Infectious Diseases and The FASEB Journal.

In The Last Decade

Mary L. Hall

31 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary L. Hall United States 13 142 124 68 64 63 31 433
Charlotte R. Kleiveland Norway 13 144 1.0× 255 2.1× 79 1.2× 42 0.7× 14 0.2× 35 594
Elisa Carloni Italy 18 70 0.5× 297 2.4× 25 0.4× 41 0.6× 102 1.6× 26 580
Arif Istiaq Japan 9 136 1.0× 177 1.4× 22 0.3× 23 0.4× 38 0.6× 17 401
Anabelle Sequeira-Le Grand France 9 156 1.1× 182 1.5× 21 0.3× 42 0.7× 19 0.3× 10 390
Maroof Husain United States 14 72 0.5× 229 1.8× 49 0.7× 21 0.3× 7 0.1× 19 544
Yannick Pereira France 10 32 0.2× 275 2.2× 51 0.8× 53 0.8× 10 0.2× 10 565
Tiago Antônio de Souza Brazil 14 33 0.2× 200 1.6× 38 0.6× 12 0.2× 8 0.1× 36 460
Natalia S. Corbalán Argentina 10 74 0.5× 214 1.7× 16 0.2× 30 0.5× 3 0.0× 15 419
Tomonori Suzuki Japan 16 35 0.2× 201 1.6× 57 0.8× 29 0.5× 6 0.1× 51 769
Young Man Kwon United States 5 73 0.5× 339 2.7× 153 2.3× 13 0.2× 4 0.1× 7 530

Countries citing papers authored by Mary L. Hall

Since Specialization
Citations

This map shows the geographic impact of Mary L. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary L. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary L. Hall more than expected).

Fields of papers citing papers by Mary L. Hall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary L. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary L. Hall. The network helps show where Mary L. Hall may publish in the future.

Co-authorship network of co-authors of Mary L. Hall

This figure shows the co-authorship network connecting the top 25 collaborators of Mary L. Hall. A scholar is included among the top collaborators of Mary L. Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary L. Hall. Mary L. Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gurr, Joshua R., Timothy J. O’Donnell, Wesley Y. Yoshida, et al.. (2020). 6-Deoxy- and 11-Hydroxytolypodiols: Meroterpenoids from the Cyanobacterium HT-58-2. Journal of Natural Products. 83(5). 1691–1695. 9 indexed citations
2.
Swanson‐Mungerson, Michelle, et al.. (2019). Biochemical and Functional Analysis of Cyanobacterium Geitlerinema sp. LPS on Human Monocytes. Toxicological Sciences. 171(2). 421–430. 8 indexed citations
4.
Swanson‐Mungerson, Michelle, et al.. (2017). Effects of cyanobacteria Oscillatoria sp. lipopolysaccharide on B cell activation and Toll-like receptor 4 signaling. Toxicology Letters. 275. 101–107. 30 indexed citations
5.
Mayer, Alejandro M. S., et al.. (2015). Classical and Alternative Activation of CyanobacteriumOscillatoriasp. Lipopolysaccharide-Treated Rat Microgliain vitro. Toxicological Sciences. 149(2). 484–495. 29 indexed citations
6.
Mayer, Alejandro M. S., Mary L. Hall, Cristina De Castro, et al.. (2014). Vibrio vulnificus MO6-24/O Lipopolysaccharide Stimulates Superoxide Anion, Thromboxane B2, Matrix Metalloproteinase-9, Cytokine and Chemokine Release by Rat Brain Microglia in Vitro. Marine Drugs. 12(4). 1732–1756. 10 indexed citations
8.
Mayer, Alejandro M. S., et al.. (2009). Granulocytic differentiation of HL-60 promyelocytic leukemia cells is associated with increased expression of Cul5. In Vitro Cellular & Developmental Biology - Animal. 45(5-6). 264–274. 18 indexed citations
9.
Hall, Mary L., et al.. (2009). Effect of Microcystis aeruginosa Lipopolysaccharide (LPS) on Neonatal Rat Brain Microglia Cytokine and Chemokine release. The FASEB Journal. 23(S1). 1 indexed citations
11.
Mayer, Alejandro M. S., et al.. (2005). Differential modulation of microglia superoxide anion and thromboxane B2 generation by the marine manzamines. BMC Pharmacology. 5(1). 6–6. 20 indexed citations
13.
Hall, Mary L. & Patrick M. Schlievert. (1999). Kawasaki Syndrome-Like Illness Associated with Infection Caused by Enterotoxin B-Secreting Staphylococcus aureus. Clinical Infectious Diseases. 29(3). 586–589. 29 indexed citations
14.
Aabo, Søren, Alison Thomas, Mary L. Hall, Henry R. Smith, & John Elmerdahl Olsen. (1992). Evaluation of a Salmonella‐specific DNA probe by colony hybridization using non‐isotopic and isotopic labeling. Apmis. 100(7-12). 623–628. 12 indexed citations
15.
Threlfall, E. J., Mary L. Hall, L Ward, & B. Rowe. (1992). Plasmid profiles demonstrate that an upsurge inSalmonella berta in humans in England and Wales is associated with imported poultry meat. European Journal of Epidemiology. 8(1). 27–33. 13 indexed citations
16.
Hall, Mary L. & B. Rowe. (1992). Salmonella arizonaein the United Kingdom from 1966 to 1990. Epidemiology and Infection. 108(1). 59–65. 43 indexed citations
17.
Threlfall, E. J., Mary L. Hall, & B. Rowe. (1983). Lactose-fermenting salmonellae in Britain. FEMS Microbiology Letters. 17(1-3). 127–130. 5 indexed citations
18.
Pegram, R. G., P. L. Roeder, Mary L. Hall, & B. Rowe. (1981). Salmonella in livestock and animal by-products in Ethiopia. Tropical Animal Health and Production. 13(1). 203–207. 8 indexed citations
19.
Hall, Mary L. & B. Rowe. (1980). Arizona 26:29:30 in sheep in the United Kingdom.. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 107(25-26). 581–2. 12 indexed citations
20.
Rowe, B., et al.. (1976). Salmonella crossness– a new serotype containing a new somatic (O) antigen, 67. Journal of Hygiene. 77(3). 355–357. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026